Galecto, Inc. - stock earnings
GLTO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -6.5 million USD | 1.2 million USD |
| 2023Q3 | -8.1 million USD | ? USD |
| 2023Q2 | -10.7 million USD | ? USD |
| 2023Q1 | -12.4 million USD | ? USD |
| 2022Q4 | -14.6 million USD | ? USD |
| 2022Q3 | -13.8 million USD | ? USD |
| 2022Q2 | -16.7 million USD | ? USD |
| 2022Q1 | -16.9 million USD | ? USD |
| 2021Q4 | -13.4 million USD | ? USD |
| 2021Q3 | -12.7 million USD | ? USD |
| 2021Q2 | -12.3 million USD | ? USD |
| 2021Q1 | -13.3 million USD | ? USD |
| 2020Q4 | -11.6 million USD | ? USD |
| 2020Q3 | -11.7 million USD | ? USD |
| 2020Q2 | -5.9 million USD | ? USD |
| 2020Q1 | -5.7 million USD | ? USD |
| 2019Q4 | -24.4 million USD | ? USD |
| 2019Q3 | -4.1 million USD | ? USD |
| 2019Q2 | -9.1 million USD | ? USD |
| 2019Q1 | -9.1 million USD | ? USD |
| 2018Q4 | -9.1 million USD | ? USD |
| 2018Q2 | -4.0 million USD | ? USD |
| 2018Q1 | -4.0 million USD | ? USD |
| 2017Q4 | -4.0 million USD | ? USD |
GLTO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -38.3 million USD | ? USD |
| 2022 | -62.0 million USD | ? USD |
| 2021 | -51.3 million USD | ? USD |
| 2020 | -36.0 million USD | ? USD |
| 2019 | -38.4 million USD | ? USD |
| 2018 | -15.9 million USD | ? USD |
GLTO
Price: $0.72
52 week price:
Earnings Per Share: -1.44 USD
P/E Ratio: -0.38
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 27417
Market Capitalization: 18.6 million